Author:
Wingender W.,Graefe K. -H.,Gau W.,Förster D.,Beermann D.,Schacht P.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology,Infectious Diseases,Microbiology (medical),General Medicine
Reference13 articles.
1. Bauernfeind, A., Petetmüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.
2. Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay o 9867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.
3. Fass, R. J.: In vitro activity of ciprofloxacin (Bay o 9867). Antimicrobial Agents and Chemotherapy 1983, 24: 568–574.
4. Caekenberghe, D. L., Pattyn, S.: In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrobial Agents and Chemotherapy 1984, 25: 518–521.
5. Felmingham, D., O'Hare, M. D., Gruneberg, R. N., Ridgway, G. L.: The comparative activity of eleven quinoline antibiotics against penicillin-sensitive, peni-cillin-resistant non-beta-lactamase producing and betalactamase producing isolates ofN. gonorrhoeae. In: Spitzy, K. H., Karrer, K. (ed.): 13th International Congress of Chemotherapy, Vienna, 1983, part 112. Verlag Egermann, Vienna, p. 27–30.
Cited by
161 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献